Cholesterol biosynthesis: a mechanistic overview

NM Cerqueira, EF Oliveira, DS Gesto… - Biochemistry, 2016 - ACS Publications
Cholesterol is an essential component of cell membranes and the precursor for the
synthesis of steroid hormones and bile acids. The synthesis of this molecule occurs partially …

Low-density lipoprotein-cholesterol-induced endothelial dysfunction and oxidative stress: the role of statins

N Hermida, JL Balligand - Antioxidants & redox signaling, 2014 - liebertpub.com
Significance: Cardiovascular diseases (CVD) represent a major public health burden. High
low-density lipoprotein (LDL)-cholesterol is a recognized pathogenic factor for …

An atomic-level perspective of HMG-CoA-reductase: The target enzyme to treat hypercholesterolemia

DS Gesto, CMS Pereira, NMFS Cerqueira, SF Sousa - Molecules, 2020 - mdpi.com
This review provides an updated atomic-level perspective regarding the enzyme 3-hydroxy-
3-methylglutaryl coenzyme A reductase (HMG-CoAR), linking the more recent data on this …

[HTML][HTML] Emerging Therapeutic Targets for Acute Coronary Syndromes: Novel Advancements and Future Directions

A Mitsis, M Myrianthefs, S Sokratous, G Karmioti… - Biomedicines, 2024 - mdpi.com
Acute coronary syndrome (ACS) remains a major cause of morbidity and mortality
worldwide, requiring ongoing efforts to identify novel therapeutic targets to improve patient …

Bioactivities of Centaurium erythraea (Gentianaceae) Decoctions: Antioxidant Activity, Enzyme Inhibition and Docking Studies

L Guedes, PBPS Reis, M Machuqueiro, A Ressaissi… - Molecules, 2019 - mdpi.com
Centaurium erythraea is recommended for the treatment of gastrointestinal disorders and to
reduce hypercholesterolemia in ethno-medicinal practice. To perform a top-down study that …

The increasingly complex mechanism of HMG-CoA reductase

BE Haines, O Wiest, CV Stauffacher - Accounts of chemical …, 2013 - ACS Publications
HMG-CoA reductase (HMGR) is the target of statins, cholesterol-lowering drugs prescribed
to millions of patients worldwide. More recent research indicates that HMGR could be a …

Statin therapy and related risk of new-onset type 2 diabetes mellitus

M Ruscica, C Macchi, B Morlotti, CR Sirtori… - European journal of …, 2014 - Elsevier
The use of statins for cardiovascular disease (CVD) prevention is clearly supported by
clinical evidence. Although statin therapy is rather well tolerated, recent data from …

Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin

L Arnaboldi, A Corsini - Atherosclerosis Supplements, 2015 - Elsevier
Statins represent the elective lipid-lowering strategy in hyperlipidemic and high
cardiovascular-risk patients. Despite excellent safety and tolerability, reversible muscle …

Molecular modeling of the reaction pathway and hydride transfer reactions of HMG-CoA reductase

BE Haines, CN Steussy, CV Stauffacher, O Wiest - Biochemistry, 2012 - ACS Publications
HMG-CoA reductase catalyzes the four-electron reduction of HMG-CoA to mevalonate and
is an enzyme of considerable biomedical relevance because of the impact of its statin …

Synthesis and highly potent hypolipidemic activity of alpha-asarone-and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors

A Mendieta, F Jiménez, L Garduño-Siciliano… - Bioorganic & medicinal …, 2014 - Elsevier
In the search for new potential hypolipidemic agents, the present study focused on the
synthesis of 2-acyl phenols (6a–c and 7a–c) and their saturated side-chain alkyl phenols (4a …